Jason O'Byrne

Insider Reports History

Location
San Francisco, CA
Signature
/s/ Vanina de Verneuil, Attorney-In-Fact
All insider transactions
Transactions in reports broken out by “transaction date” reported in original SEC filing, see here for transactions aggregated across transaction date

Holdings reported by Jason O'Byrne:

Stock Role Class Num Shares Value Price $ Report Date Ownership
Vir Biotechnology, Inc. EVP & Chief Financial Officer Common Stock 111K $615K $5.56 17 Nov 2025 Direct
Caribou Biosciences, Inc. Chief Financial Officer Option to purchase Common Stock 153K $352K $2.69 20 Feb 2024 Direct
Caribou Biosciences, Inc. Chief Financial Officer Common Stock 59.2K $159K $2.69 20 Feb 2024 Direct
Vir Biotechnology, Inc. EVP & Chief Financial Officer Stock Option (Right to Buy) 80K $122K $1.53 22 Feb 2025 Direct

Insider Reports Filed by Jason O'Byrne

Symbol Company Period Transactions Value $ Form Type Date Filed Role
VIR Vir Biotechnology, Inc. 17 Nov 2025 1 -$37.8K 4 18 Nov 2025 EVP & Chief Financial Officer
VIR Vir Biotechnology, Inc. 22 Feb 2025 2 $0 4 25 Feb 2025 EVP & Chief Financial Officer
VIR Vir Biotechnology, Inc. 15 Nov 2024 2 $0 4 18 Nov 2024 EVP & Chief Financial Officer
VIR Vir Biotechnology, Inc. 02 Oct 2024 0 $0 3 03 Oct 2024 EVP & Chief Financial Officer
CRBU Caribou Biosciences, Inc. 20 Feb 2024 2 $0 4 22 Feb 2024 Chief Financial Officer
CRBU Caribou Biosciences, Inc. 21 Feb 2023 1 $0 4 23 Feb 2023 Chief Financial Officer
CRBU Caribou Biosciences, Inc. 08 Feb 2022 2 $100K 4 08 Feb 2022 Chief Financial Officer
CRBU Caribou Biosciences, Inc. 20 Dec 2021 1 $0 4 21 Dec 2021 Chief Financial Officer
CRBU Caribou Biosciences, Inc. 22 Jul 2021 0 $0 3 22 Jul 2021 Chief Financial Officer Exhibit 24 - Power of Attorney.